Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-31 @ 1:18 AM
Study NCT ID:
NCT01025232
Status:
TERMINATED
Last Update Posted:
2017-01-02
First Post:
2009-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Sponsor:
David M. Brown, M.D.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FVF4571s
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |